InvestorsHub Logo
Followers 448
Posts 7031
Boards Moderated 1
Alias Born 08/09/2009

Re: None

Monday, 12/10/2012 8:16:25 AM

Monday, December 10, 2012 8:16:25 AM

Post# of 37779
A leukemia therapy that Novartis $NVS bought from the University of Pennsylvania has freed nine out of 12 patients of the blood cancer. The treatment works by taking the sufferers' immune cells, reprogramming them to target leukemia cells, and then re-injecting them into the patients. Novartis will call the treatment CTL019.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.